ProKidney Corp.
ProKidney Corp. (PROK) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
prok · stock forecast · 8 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 8 Wall Street analysts in the past 3 months
Buy
8 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$6.00
Consensus
$4.67
+173.1% upside
Low
$3.00
Median: $5 · Last Close: $1.71
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$4.67
173.1% upside
High Target
$6
250.9%
Low Target
$3
75.4%
Current Price
$1.71
as of today
Based on analyst price targets, the PROK stock price prediction for the next 12 months ranges from $3 to $6. The consensus PROK price forecast of $4.67 implies 173.1% upside from the current price of $1.71.
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.75 | ↑ 2.31% |
1-day model range: $1.73–$1.77. Peak: $1.77 (+2.31%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PROK · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-07-15 | UBS | Maintains | Buy→Buy |
| 2025-07-14 | Guggenheim | Maintains | Buy→Buy |
| 2025-07-09 | Citigroup | Maintains | Buy→Buy |
| 2025-06-30 | B of A Securities | Downgrade ↓ | Neutral→Underperform |
| 2024-09-04 | B of A Securities | Maintains | Neutral→Neutral |
| 2024-06-10 | Jefferies | Maintains | Buy→Buy |
| 2024-05-29 | B of A Securities | Maintains | Neutral→Neutral |
| 2024-01-02 | B of A Securities | Downgrade ↓ | Buy→Neutral |
| 2022-12-21 | Jefferies | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on ProKidney Corp. (PROK) stock. Of the recent 14 rating actions, 0 were upgrades and 2 were downgrades. 8 analysts currently cover PROK.
Analyst Recommendation Trends
PROK analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1M
↓ 99.1% YoY
Revenue Next Year
$0M
↓ 12.0% YoY
EPS This Year
$-0.64
EPS Next Year
$-0.66
↑ 2.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast PROK EPS of $-0.64 for the current fiscal year, based on estimates from 3 analysts. The PROK revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PROK stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PROK price target is $4.67 (+173.1% upside), with an analyst consensus of Buy.
The PROK short-term stock prediction for tomorrow is $1.75 (+2.31%).
ProKidney Corp. trades on NASDAQ under the ticker PROK. The PROK stock outlook for 2027 is broadly positive, supported by a Buy consensus among 75% of covering analysts.
Frequently asked questions
PROK forecast · 8 questionsAccording to 8 Wall Street analysts, the average 12-month PROK price target is $4.67, with a high forecast of $6.00 and a low of $3.00. The median price target is shown in the chart above when available. This implies +173.1% potential upside from the current price of $1.71.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.